Julie Holzrichter
CIK 1409442 · View on SEC EDGAR ↗
First SEC filing: Aug. 16, 2007 · Latest: Aug. 16, 2007
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 15, 2023 | CME | S | 6,000 | $205.47 | $1,232,820 | 31,990 Direct | -15.79% | Disposed | 32.9% (price as of 2026-08-21) |
| Nov. 11, 2021 | CME | S | 5,000 | $220.81 | $1,104,050 | 33,713 Direct | -12.92% | Disposed | 23.7% (price as of 2026-08-21) |
| May 12, 2021 | CME | S | 6,000 | $213.29 | $1,279,740 | 36,479 Direct | -14.12% | Disposed | 28.0% (price as of 2026-08-21) |
| Dec. 1, 2020 | CME | S 10b5-1 | 3,188 | $180.00 | $573,840 | 37,433 Direct | -7.85% | Disposed | 51.7% (price as of 2026-08-21) |
| June 5, 2020 | CME | S 10b5-1 | 3,090 | $190.31 | $588,058 | 38,001 Direct | -7.52% | Disposed | 43.5% (price as of 2026-08-21) |
| April 6, 2020 | CME | S 10b5-1 | 3,011 | $180.00 | $541,980 | 41,091 Direct | -6.83% | Disposed | 51.7% (price as of 2026-08-21) |
| Feb. 28, 2020 | CME | S 10b5-1 | 3,061 | $203.37 | $622,516 | 37,284 Direct | -7.59% | Disposed | 34.3% (price as of 2026-08-21) |
| Sept. 3, 2019 | CME | S 10b5-1 | 3,436 | $216.07 | $742,417 | 38,704 Direct | -8.15% | Disposed | 26.4% (price as of 2026-08-21) |
| June 3, 2019 | CME | S 10b5-1 | 3,973 | $192.25 | $763,809 | 42,140 Direct | -8.62% | Disposed | 42.0% (price as of 2026-08-21) |
| June 3, 2019 | CME | S 10b5-1 | 268 | $192.45 | $51,577 | 46,113 Direct | -0.58% | Disposed | 41.9% (price as of 2026-08-21) |
| March 1, 2019 | CME | S 10b5-1 | 4,362 | $182.45 | $795,847 | 41,265 Direct | -9.56% | Disposed | 49.7% (price as of 2026-08-21) |
| Nov. 6, 2018 | CME | S | 3,353 | $186.71 | $626,039 | 45,627 Direct | -6.85% | Disposed | 46.2% (price as of 2026-08-21) |
| Nov. 28, 2017 | CME | S | 8,340 | $144.08 | $1,201,627 | 40,983 Direct | -16.91% | Disposed | 89.5% (price as of 2026-08-21) |
| Nov. 28, 2017 | CME | S | 4,580 | $144.08 | $659,886 | 40,983 Direct | -10.05% | Disposed | 89.5% (price as of 2026-08-21) |
| Aug. 7, 2017 | CME | S | 6,040 | $125.67 | $759,047 | 37,782 Direct | -13.78% | Disposed | 117.3% (price as of 2026-08-21) |
| Aug. 7, 2017 | CME | S | 5,875 | $125.67 | $738,311 | 37,782 Direct | -13.46% | Disposed | 117.3% (price as of 2026-08-21) |
| June 7, 2017 | CME | S | 1,625 | $118.23 | $192,124 | 37,782 Direct | -4.12% | Disposed | 131.0% (price as of 2026-08-21) |
| June 7, 2017 | CME | S | 4,300 | $118.23 | $508,389 | 37,782 Direct | -10.22% | Disposed | 131.0% (price as of 2026-08-21) |
| Feb. 28, 2017 | CME | S | 600 | $122.46 | $73,476 | 34,429 Direct | -1.71% | Disposed | 123.0% (price as of 2026-08-21) |
Showing latest 100 of 138 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 28, 2017 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (4,580) | $54.37 | Sept. 15, 2021 | 4,580 | Disposed |
| Nov. 28, 2017 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (8,340) | $54.30 | Sept. 15, 2020 | 8,340 | Disposed |
| Aug. 7, 2017 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (5,875) | $83.88 | June 16, 2018 | 5,875 | Disposed |
| Aug. 7, 2017 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (6,040) | $56.87 | Sept. 15, 2019 | 6,040 | Disposed |
| June 7, 2017 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (1,625) | $109.72 | Sept. 14, 2017 | 1,625 | Disposed |
| June 7, 2017 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (4,300) | $110.54 | June 15, 2017 | 4,300 | Disposed |
| Feb. 28, 2017 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (600) | $106.58 | March 15, 2017 | 600 | Disposed |
| Aug. 4, 2016 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (2,425) | $90.75 | Sept. 15, 2016 | 2,425 | Disposed |
| Sept. 15, 2011 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (916) | $271.86 | Sept. 15, 2021 | 916 | Acquired |
| Sept. 15, 2010 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (1,668) | $271.49 | Sept. 15, 2020 | 1,668 | Acquired |
| Sept. 15, 2009 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (1,208) | $284.34 | Sept. 15, 2019 | 1,208 | Acquired |
| June 16, 2008 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (1,175) | $419.41 | June 16, 2018 | 1,175 | Acquired |
| Sept. 14, 2007 | CME | Non-Qualified Stock Option (right to buy) | Common Stock Class A (325) | $548.60 | Sept. 14, 2017 | 325 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 16, 2007 | CME | Non-Qualified Stock Option (right to buy)→ Common Stock Class A | — | Direct |
| Aug. 16, 2007 | CME | Non-Qualified Stock Option (right to buy)→ Common Stock Class A | — | Direct |
| Aug. 16, 2007 | CME | Non-Qualified Stock Option (right to buy)→ Common Stock Class A | — | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CME
COO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $500,000 | — | — | — | $532,500 | $75,120 | $82,021 | $3,011,764 |
| 2019 | $500,000 | — | — | — | $610,451 | $87,941 | $146,759 | $2,999,330 |
| 2018 | $475,000 | — | — | — | $830,077 | $2,091 | $79,037 | $3,235,947 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.